Citation Impact
Citing Papers
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
1996
A case–control study comparing the incidence of early symptoms in pancreatic and biliary tract cancer
2014
Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis
2017
Regulatory T-cell directed therapies in liver diseases
2013 StandoutNobel
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Hepatocellular carcinoma screening in patients waiting for liver transplantation: A decision analytic model
2003
Analysis of 388 cases of primary sclerosing cholangitis in JapanPresence of a subgroup without pancreatic involvement in older patients
2004
Chimerism of the Transplanted Heart
2002 Standout
Hepatocellular carcinoma
2003 Standout
Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case–control study in Italy
2001
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
2000 Standout
Primary sclerosing cholangitis: Refinement and validation of survival models
1992
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
2001 Standout
Autoimmune hepatitis
2018
Molecular and histological correlations in liver cancer
2019
Hepatocellular carcinoma
2018 Standout
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation
2004
Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis
2008
Burden of liver diseases in the world
2018 Standout
Screening for hepatocellular carcinoma
1998
Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
2013
Human Hepatocyte Transplantation: Worldwide Results
2006
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
2003 Standout
Diagnosis and Management of Autoimmune Hepatitis
2010
Gastric and Ectopic Varices
2014
Pancreatic cancer
2016 Standout
Hepatocellular carcinoma
2012 Standout
Primary Sclerosing Cholangitis
2005
Hepatobiliary surgery
2000
Hepatocellular carcinoma
2021 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Autoimmune hepatitis
2011
Expanding consensus in portal hypertension
2015 Standout
Vascular disorders of the liver # †
2008 Standout
Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma
1998
Immunoglobulin G4–Associated Cholangitis: Clinical Profile and Response to Therapy
2008 Standout
Portal hypertension and variceal bleeding—Unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference
2008
Management of Hepatocellular Carcinoma: An Update Δσ
2011 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
2015 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Photodynamic Therapy for Pancreatic and Biliary Tract Carcinoma
2005
Portal hypertensive bleeding in cirrhosis
2016 Standout
Liver transplantation: Current status and novel approaches to liver replacement
2001
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
Model for end-stage liver disease (MELD) and allocation of donor livers
2003 Standout
Inflammatory Bowel Disease
2002 Standout
MELD and PELD: Application of survival models to liver allocation
2001
Sclerosing cholangitis: A focus on secondary causes
2006
Epidemiology of cholangiocarcinoma
2015
The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis
1997
AGA technical review on intestinal ischemia
2000 Standout
Cutting edge issues in autoimmune hepatitis
2016
Annual Incidence of Hepatocellular Carcinoma Among Patients With Alcoholic Cirrhosis and Identification of Risk Groups
2012
Resection and Liver Transplantation for Hepatocellular Carcinoma
2005
Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis
2004
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
IgG4-related disease
2014 Standout
Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis
2007 Standout
Mesenteric Venous Thrombosis
2013
Oral budesonide in the treatment of primary sclerosing cholangitis
2000
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
Primary sclerosing cholangitis
1999
Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a united states community
2003
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Induced pluripotent stem cell–derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice
2010 StandoutNobel
Survival and Recurrence After Liver Transplantation Versus Liver Resection for Hepatocellular Carcinoma
1998
Hepatocellular Carcinoma
2011 Standout
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
2020 Standout
Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic power
1998
New therapeutic strategies for hepatitis C
2002 StandoutNobel
Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study
2002
Primary sclerosing cholangitis – a comprehensive review
2017
Update on primary sclerosing cholangitis
2013
A Fibrosis‐Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis
2020 StandoutNobel
Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
2016
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Autoimmune pancreatocholangitis: A series of ten patients
2006
Nationwide survey for primary sclerosing cholangitis and IgG 4‐related sclerosing cholangitis in J apan
2013
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
2007 StandoutNobel
Helicobacter species infection may be associated with cholangiocarcinoma: a meta-analysis
2013
Course of Crohn's disease after allogeneic marrow transplantation
1998
Comparison of Percutaneous Acetic Acid Injection and Percutaneous Ethanol Injection for Hepatocellular Carcinoma in Cirrhotic Patients: A Prospective Study
2003
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
2014 Standout
Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.
1997
Inflammatory Bowel Disease
2010 Standout
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four α-Fetoprotein Peptides
2006
Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis
2013
Surveillance for hepatocellular carcinoma
2014
Detection of Hepatocellular Carcinomas and Dysplastic Nodules in Cirrhotic Livers
2000
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Chromatin-Bound p53 Anchors Activated Smads and the mSin3A Corepressor To Confer Transforming Growth Factor β-Mediated Transcription Repression
2008
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Animal models of autoimmune hepatitis
2010
Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management
2010
Works of John Karani being referenced
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
2012
Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation
2011
Microbubble ultrasound contrast in the assessment of hepatic artery patency following liver transplantation: role in reducing frequency of hepatic artery arteriography
2004
Angiographically determined arteriopathy in liver graft dysfunction and survival
1993
Liver disease in children with primary immunodeficiencies
2004
Natural history and prognostic variables in primary sclerosing cholangitis
1991
Split Liver Transplantation
1998
Accuracy of radiology in detection of hepatocellular carcinoma before liver transplantation
1994
Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening
2008
Chronic Mesenteric Venous Thrombosis: Evaluation and Determinants of Survival During Long-Term Follow-up
2006
α-Fetoprotein Impairs APC Function and Induces Their Apoptosis
2004
Internal biliary drainage and local radiotherapy with iridium-192 wire in treatment of hilar cholangiocarcinoma
1985
ONE LIVER, THREE RECIPIENTS: SEGMENT IV FROM SPLIT-LIVER PROCEDURES AS A SOURCE OF HEPATOCYTES FOR CELL TRANSPLANTATION
2004